Bernie Sanders Calls for Reduction of Ozempic Drug Prices by Novo Nordisk

Bernie Sanders wants Novo Nordisk, a big company in Denmark, to lower the prices of its popular weight loss and diabetes drugs, Ozempic and Wegovy. He thinks the prices in the U.S. are too high. Novo Nordisk makes a lot of money from these drugs, but many people can't afford them. Sanders wrote in a Danish newspaper, asking people in Denmark to push Novo Nordisk to reduce the prices of these drugs in the U.S. and other countries. He believes that these drugs could help many people worldwide, but only if they are more affordable. Novo Nordisk's profits have been increasing because of the high demand for Ozempic and Wegovy. Sanders has been questioning Novo Nordisk about the prices of their medications. He is worried that the high prices in the U.S. could cause problems for the healthcare system. Novo Nordisk's market value has grown a lot in recent years, making it one of the biggest companies globally. Sanders thinks that Novo Nordisk should lower the prices of Ozempic and Wegovy because they are too expensive, especially in the U.S. He believes that the company is not living up to its moral standards by charging so much. The cost of these drugs is much lower in some European countries compared to the U.S. Novo Nordisk argues that the prices in the U.S. have actually decreased by 40% since 2018. Ozempic is mainly used to treat diabetes but can also help with weight loss. It is very effective, with patients being able to lose a significant amount of weight. Novo Nordisk executives say that the focus should be on the value these drugs provide in improving health, rather than just the costs. There are concerns about the rising prices of these drugs, which have many health benefits. Denmark has recently made changes to how Ozempic is prescribed to control costs. Sanders has been in contact with Novo Nordisk to discuss the issue of drug prices and patient access. The company's CEO has spoken with Sanders and testified before the committee. Novo Nordisk believes that healthcare systems vary by country, and comparing prices without considering these differences can be misleading.